News

Individuals with frontotemporal degeneration (FTD) may soon benefit from research priorities directed toward curing Alzheimer’s disease and other forms of dementia. The Association of Frontotemporal Degeneration (AFTD) broke word of plans to formally include FTD in national research priorities by the year 2025. According to AFTD Executive Director Susan…

Typical daily tasks may not seem like the type that require high brain function. However, activities within our daily routine, which include paying the bills, going to appointments, and even driving — all of which are known as “instrumental activities” — are directly linked to optimal performance in specific…

A new free access paper published online before print in the journal JAMA Neurology, entitled, “Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function” (JAMA Neurol. Published online August 11, 2014. DOI: 10.1001/.jamaneurol.2014.2011) documents a 40-year-old African American man referred…

The California Supreme Court recently decided, by a 5-2 decision, that people with Alzheimer’s disease cannot be held responsible for injuries caused to their in-home caregivers, and that a prior awareness of this fact precludes a legal accusation, CBS News recently reported, quoting an Associated Press report. According…

Vitamin D, known as the sunshine vitamin due to its mechanism of production in the body, is usually associated with calcium absorption and bone health, but researchers are finding that vitamin D is strongly linked to the risk for Alzheimer’s disease and dementia. Dr. David Llewellyn, from the University…

Increasing incidence of Alzheimer’s Disease and other forms of senile dementia as the population demographic ages has raised general anxiety levels. It’s not entirely paranoia. Risk of developing Alzheimer’s doubles every five years after age 65. Toronto, Canada-based Cogniciti, Inc. cites a recent Brain Health Study (about which more…

Researchers at Yale School of Medicine have discovered a new drug compound with the capacity to reverse the brain deficits of Alzheimer’s disease (AD) in an animal model. In this month’s issue of PLoS Biology, in an article entitled, “Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits…

A set of recent studies indicate that the rate of Alzheimer’s disease and other forms of dementia is decreasing in some of the wealthiest nations around the world — including the U.S. According to an article by David Green on The Legacy, research conducted in England,…

A simple test that measures how fast people walk and whether they have cognitive issues can determine how likely they are to develop dementia, which includes diseases such as Alzheimer’s, within 12 years. These are the conclusions of a study led by scientists at the Albert Einstein College of…

Recent results from Prana Biotechnology’s IMAGINE Alzheimer’s trial, released earlier this year (March), as well as the company’s ongoing sub-analysis, has suggested to the company’s research team that further analysis of the PiB-PET Standardized Uptake Value Ratio (SUVR) and the tendency towards preservation of brain volume in PBT2 treated patients may be necessary. The results…